A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetic Medicine

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dme.12515PMID 24909998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comment on ‘A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure’

  2015cited by this paper
• Metformin in Peritoneal Dialysis: A Pilot Experience

  2014cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Type 2 diabetes mellitus in 2012: Optimal management of T2DM remains elusive

  2013cited by this paper
• Biomarkers and creatinine in AKI: the trough of disillusionment or the slope of enlightenment?

  2013cited by this paper
• Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

  2013cited by this paper
• Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

  2013cited by this paper
• Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study

  2013cited by this paper
• Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.

  2013cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register

  2012cited by this paper
• Metformin and its clinical use: new insights for an old drug in clinical practice

  2012cited by this paper
• Metformin therapy in patients with chronic kidney disease

  2012cited by this paper
• Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

  2011cited by this paper
• Metformin and Chronic Renal Impairment: A Story of Choices and Ugly Ducklings

  2011cited by this paper
• Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?

  2011cited by this paper
• Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

  2011cited by this paper
• Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment

  2011cited by this paper
• Metformin use and mortality among patients with diabetes and atherothrombosis.

  2010cited by this paper
• A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes

  2009cited by this paper
• Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature.

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Do contraindications to metformin therapy deprive type 2 diabetic patients of its benefits?

  2008cited by this paper
• Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia

  2008cited by this paper
• Population Exposure‐Response Modeling of Metformin in Patients With Type 2 Diabetes Mellitus

  2008cited by this paper
• Metformin‐associated lactic acidosis in patients with renal impairment solely due to drug accumulation?

  2006cited by this paper
• Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

  2005cited by this paper
• Metformin and lactic acidosis: cause or coincidence? A review of case reports

  2004cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2003cited by this paper
• Combination of insulin and metformin in the treatment of type 2 diabetes.

  2002cited by this paper
• The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin.

  2002cited by this paper
• Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes.

  2002cited by this paper
• The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study.

  2001cited by this paper
• Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.

  1999cited by this paper
• Metformin and contrast media--a dangerous combination?

  1999cited by this paper
• Metformin‐associated lactic acidosis: a rare or very rare clinical entity?

  1999cited by this paper
• Contra‐indications to metformin therapy are largely disregarded

  1999cited by this paper
• Lactic acidosis in patients with diabetes treated with metformin.

  1998cited by this paper
• Lactic Acidosis Rates in Type 2 Diabetes

  1998cited by this paper
• Metformin treatment in NIDDM patients with mild renal impairment.

  1996cited by this paper
• Kidney Function and Age Are Both Predictors of Pharmacokinetics of Metformin

  1995cited by this paper
• Role of Metformin Accumulation in Metformin-Associated Lactic Acidosis

  1995cited by this paper
• Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

  1981cited by this paper
• Pharmacokinetics of metformin after intravenous and oral administration to man

  1979cited by this paper
• Phenformin-associated Metabolic Acidosis

  1976cited by this paper

• A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin

  2022cites this paper
• Drug-Induced Metabolic Acidosis [version 1; peer review: 3 approved]

  2022cites this paper
• An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist.

  2021cites this paper
• Metformin Associated Lactic Acidosis in Clinical Practice - A Case Series.

  2020cites this paper
• Monitoring and management of hyperglycemia in patients with advanced diabetic kidney disease.

  2020cites this paper
• Decreased comorbidities in rheumatoid arthritis patients treated with a biologic agent

  2020cites this paper
• Incidence and risk factors for hyperlactatemia in ED patients with acute metformin overdose.

  2019cites this paper
• Metformin associated lactic acidosis resulted in cardiopulmonary arrest: a rare case Kardiyopulmoner arrest ile sonuçlanan metformin ilişkili laktik asidoz: nadir bir olgu

  2018cites this paper
• Metformin protects renal tubular cells; mechanisms and new concepts

  2018cites this paper
• Metformin-Associated Lactic Acidosis: A Case Report

  2018cites this paper
• Metformin in cancer.

  2018cites this paper
• Hypoglycemia and severe lactic acidosis in a dog following metformin exposure

  2017cites this paper
• Häufung schwerer Metformin-assoziierter Laktatazidosen

  2017cites this paper
• Pilot study of oral metformin in cancer‐bearing cats

  2017cites this paper
• 37th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 16–19 May 2017, Basel, Switzerland

  2017cites this paper
• Could metformin be used in patients with diabetes and advanced chronic kidney disease?

  2017cites this paper
• [Accumulation of Metformin-associated Lactic Acidosis].

  2017cites this paper
• Refining metformin prescribing in New Zealand.

  2017cites this paper
• Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients

  2017cites this paper
• Therapeutic Concentrations of Metformin: A Systematic Review

  2016cites this paper
• Metformin and lactic acidosis during shock

  2016cites this paper
• Metformin associated lactic acidosis (MALA): clinical profiling and management

  2016cites this paper
• [Differential characteristics of type 2 diabetes in the elderly. Role of dipeptidyl peptidase 4 inhibitors].

  2016cites this paper
• Metformin-associated lactic acidosis: Current perspectives on causes and risk.

  2016cites this paper
• Factores asociados a mortalidad por acidosis láctica en pacientes diabéticos tratados con metformina

  2016cites this paper
• Metformin and lactic acidosis during shock: just the tip of the iceberg?

  2016cites this paper
• [Factors associated with death due to lactic acidosis in patients with type-2 diabetes treated with metformin].

  2016cites this paper
• Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease

  2016influential citation
• Comment on ‘A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure’

  2015cites this paper
• Metformin as a cellular protector; a synoptic view of modern evidences

  2015cites this paper
• Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus.

  2015influential citation
• Metformin Associated Lactic Acidosis

  2015cites this paper
• Response to Rosival: Pathophysiology of diabetic ketoacidosis

  2015cites this paper
• Drug-Induced Metabolic Acidosis

  2015cites this paper
• Comment on ‘A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure’

  2015cites this paper
• Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base

  2015cites this paper
• Metabolic Acidosis and Rhabdomyolysis with Metformin Overdosage

  2015cites this paper